Company Overview
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
KNSARevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
678M
2025 FY
Net Income
59M
2025 FY
Shares Outstanding
74M
2025 FY
EPS
0.8USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1730430
Exchange
Nasdaq
Location
BM